Document:

Exhibit
10.9

 

BOARD
OBSERVER AGREEMENT

 

This
Board Observer Agreement (this Agreement) is made effective July 14, 2021 (the Effective Date), by and among,

 

SAMUEL
TULLMAN, an individual residing in the City of Seattle, in the State of Washington and

 

GLEN
TULLMAN, an individual residing in the City of Chicago, in the State of Illinois, and

 

LEIIO
WELLNESS LTD., a corporation incorporated and subsisting pursuant to the laws of the Province of Alberta (the Corporation).

 

For
the purposes of this Agreement:

 

	 	A.	Samuel
    Tullman and Glen Tullman are together referred to herein as the Designating Shareholders); and
	 	 	 
	 	B.	The
    term Parties means, collectively, the Designating Shareholders and the Corporation, and the term Party means any one
    of them as the context requires.

 

RECITALS:

 

	A.	The
    Corporation is conducting a private placement offering (the “Offering”) of units of the Corporation (the “Units”)
    at a price of CDN $0.35 per Unit. Each Unit consists of one common share of the Corporation (a “Common Share”)
    and one half of one Common Share purchase warrant of the Corporation, (each whole Common Share purchase warrant, a “Warrant”).
    Each Warrant shall entitle the holder thereof to acquire one Common Share in the capital of the Corporation (a “Warrant
    Share”) at an exercise price of CDN $0.50 per Warrant Share.
	 	 
	B.	The
    Corporation and Samuel Tullman have entered into a Subscription Agreement dated July14, 2021 for the purchase by Samuel Tullman of
    1,721,429 Units.
	 	 
	C.	The
    Corporation and Glen Tullman, in his capacity as trustee for Glen E. Tullman Revocable Trust, have entered into a Subscription Agreement
    dated July14, 2021 for the purchase by Glen E. Tullman Revocable Trust of 1,721,429Units.
	 	 
	D.	As
    an inducement to the Designating Shareholders to subscribe for the aforementioned Units pursuant to the aforementioned Subscription
    Agreements, the Corporation desires to provide the Designating Shareholders with the right to appoint a single representative (the
    Observer) to attend formal meetings of the Corporation’s board of directors (the Board), as further described,
    and subject to the terms and conditions set forth, herein.
	 	 
	E.	The
    Designating Shareholders desire to appoint Sam Tullman as the Observer.

 

NOW
THEREFORE for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as
follows:

 

ARTICLE
1

OBSERVER
RIGHTS AND OBLIGATIONS

 

	1.1	The
    Corporation hereby grants the Observer the right, on behalf of the Designating Shareholders, to attend at, receive notice of, and
    observe all of the formal meetings of the Board (including telephonic or videoconference meetings of the Board) (collectively, the
    Board Meetings) strictly in a non-voting and observer capacity subject to the terms and conditions of this Agreement.

 

    	 

    	 

    

 

	1.2	The
    Designating Shareholders hereby acknowledge and agree that Sam Tullman shall be appointed as the Observer as of the Effective
    Date. The Corporation agrees that the Designating Shareholders may, by written notice executed by both Designating Shareholders and
    delivered to the Corporation, appoint a different individual to act as the Observer under this Agreement from time to time during
    the currency of this Agreement.
	 	 
	1.3	The
    Parties acknowledge and agree that prior to and as a condition to the effectiveness of the rights of the Observer contained in this
    Agreement including, but not limited to, the Observer’s rights to attend Board Meetings, any Observer appointed from time to
    time pursuant to the terms and conditions of this Agreement shall execute and deliver to the Corporation a copy of the acknowledgement
    and agreement in the form attached as Exhibit A to this Agreement (the Acknowledgement).
	 	 
	1.4	Subject
    to Section 1.3, the Corporation shall provide to the Observer copies of all notices, minutes, consents and other materials
    that it provides to Board members in advance of and for such formal board meetings (collectively, the Board Materials), including
    any draft versions, proposed written consents, and exhibits and annexes to any such materials, at the same time and in the same manner
    as such information is delivered to the Board members.
	 	 
	1.5	Subject
    to Section 1.3, the Corporation acknowledges and agrees that the Observer may participate in discussions at Board Meetings,
    but in no event shall the Observer: (a) be deemed to be a member of the Board in any way whatsoever; (b) have or be deemed to have,
    or otherwise be subject to, any duties (fiduciary or otherwise) to the Corporation or its shareholders; or (c) have the right to
    vote on, propose or offer any motions or resolutions to the Board.
	 	 
	1.6	The
    Parties acknowledge and agree that the presence of the Observer at any Board Meetings shall not be required for purposes of establishing
    a quorum of the Board at such Board Meetings.
	 	 
	1.7	Notwithstanding
    anything herein to the contrary, the Parties acknowledge and agree that the Corporation may exclude the Observer from access to any
    Board Meetings, Board Materials or any portion thereof from time to time if the Board concludes, acting in good faith and upon written
    advice from the Corporation’s counsel, that: (a) such exclusion is reasonably necessary to preserve solicitor-client or litigation
    privilege between the Corporation and its counsel (provided that any such exclusion shall only apply to such portion of such
    meeting or such material which would be required to preserve such privilege); (b) such Board meetings or Board Materials or discussion
    thereof relates directly to the Corporation’s relationship, contractual or otherwise, with the Designating Shareholders, the
    Observer or any principals, affiliates or associates of the Designating Shareholders or the Observer or any actual or potential transactions
    or disputes between or involving the Corporation, the Designating Shareholders, the Observer, or any principals, affiliates or associates
    of the Designating Shareholders or the Observer; (c) such exclusion is necessary to avoid a conflict of interest or disclosure that
    is restricted by any agreement or laws to which the Corporation is a party or otherwise bound; or (d) the Observer or the Designating
    Shareholders have breached any of the terms and conditions of this Agreement provided that such exclusion shall remain in effect
    only for such period of time as such breach remains outstanding and unrectified by the Observer or the Designating Shareholders,
    as the case may be.

 

ARTICLE
2

CONFIDENTIAL
INFORMATION

 

	2.1	To
    the extent that any information obtained by the Observer from the Corporation (or any director, officer, employee or agent thereof)
    is Confidential Information (as defined below), the Observer and the Designating Shareholders agree that they shall each treat any
    of such Confidential Information as confidential in accordance with the terms and conditions set out in this Article 2 and
    further subject to any other agreements entered into by the Parties with the Corporation as it relates to its confidential or proprietary
    information.

 

    	2

    	 

    

 

	2.2	In
    this Agreement, the term Confidential Information means any and all information or data concerning the Corporation, whether
    in verbal, visual, written, electronic or other form, which is disclosed to the Observer by the Corporation or any director, officer,
    employee or agent of the Corporation (including all Board Materials) on or after the Effective Date, together with all information
    discerned from, based on or relating to any of the foregoing which may be prepared or created by the Observer, the Designating Shareholders
    or any of their affiliates, or any of their respective directors, officers, employees, agents or advisors (each, a Representative);
    provided that Confidential Information shall not include information that:

 

	 	(a)	is,
    at the time of disclosure, or thereafter becomes, a part of the public domain through no violation of this Agreement;
	 	 	 
	 	(b)	as
    confirmed by written records, is hereafter lawfully acquired by the Designating Shareholders or the Observer through a third party
    who has lawfully acquired such information and who is under no obligation of confidence to the Corporation or any director, officer,
    employee or agent of the Corporation and which third party was not in a contractual or fiduciary relationship with the Corporation
    or any director, officer, employee or agent of the Corporation;
	 	 	 
	 	(c)	is
    permitted to be disclosed by express written consent of the Corporation prior to such disclosure being made; or
	 	 	 
	 	(d)	as
    confirmed by written records, is independently developed by the Designating Shareholders or the Observer without reference to or
    use of, in whole or in part, any of the Confidential Information.

 

	2.3	During
    the term of this Agreement and for a period of two years thereafter, the Designating Shareholders and the Observer agree to:

 

	 	(a)	retain
    all Confidential Information in strict confidence;
	 	 	 
	 	(b)	not
    release or disclose Confidential Information in any manner to any other person (other than disclosures to the Designating Shareholders
    and their lawyers, accountants, consultants, bankers and financial advisors who: (i) have a need to know such information; and (ii)
    are informed of its confidential nature); and
	 	 	 
	 	(c)	use
    the Confidential Information solely in connection with the rights of the Designating Shareholders and Observer hereunder and not
    for any other purpose unless permitted by applicable laws in which case, the Designating Shareholders and the Observer shall deliver
    written notice of the intention to disclose such Confidential Information prior to such disclosure so that the Corporation may take
    such action, at its expense, as it deems necessary to prevent such disclosure and, in any event, the Designating Shareholders and
    the Observer agree that such disclosure shall be limited only to that portion of the Confidential Information which is required to
    be disclosed by applicable laws.

 

	2.4	The
    Designating Shareholders and the Observer acknowledge and agree that the Confidential Information is proprietary to the Corporation
    and may include trade secrets or other business information, the disclosure of which could harm the Corporation. Neither of the Designating
    Shareholders nor the Observer shall, by virtue of the Corporation’s disclosure of, or such person’s use of any Confidential
    Information, acquire any rights with respect thereto, all of which rights (including intellectual property rights) shall remain exclusively
    with the Corporation. The Designating Shareholders shall have joint and several liability to the Corporation for any breach of this
    Section 2.4 by the Observer.

 

    	3

    	 

    

 

	2.5	The
    Designating Shareholders agree that, upon such Designating Shareholder ceasing to be a shareholder of the Corporation, it shall promptly:
    (a) return or destroy, at the Corporation’s option, all physical materials containing or consisting of Confidential Information
    and all hard copies thereof in their possession or control; and (b) destroy all electronically stored Confidential Information in
    their possession or control. Such Designating Shareholder shall also promptly execute and deliver to the Corporation a certificate,
    in form and substance satisfactory to the Corporation acting reasonably, that it has complied with the provisions of this Section
    2.5.

 

ARTICLE
3

NOTICES

 

	3.1	Notices
    in connection with this Agreement are to be delivered in writing:

 

	 	(a)	If
    to the Corporation:	Leiio
    Wellness Ltd.

    c/o
    Nerland Lindsey LLP

    1400,
    350 – 7th Avenue SW

    Calgary,
    Alberta T2P 3N9

    Attention:
    Darcy Campbell

    Email:
    darcy@leiio.com

	 	 	 	 
	 	(b)	If
    to Sam Tullman (the Observer):	Samual
    Tullman

    1916
    17th Ave. S.

    Seattle,
    Washington 98144 USA

    Email:
    samatullman@gmail.com

	 	 	 	 
	 	(c)	If
    to Glen Tullman:	Glen
    Tullman

    250
    E. Pearson St., Apt 1205

    Chicago,
    Illinois 60611-7290 USA

    Email:
    glentullman@gmail.com

 

or
to such other address as may be given by each Party from time to time under this Section 3.1. Notices shall be deemed properly
given upon delivering the same by “.pdf” email attachment, or by personal delivery, the day following deposit by overnight
carrier, or five days after deposit in Canada Post or US mail.

 

ARTICLE
4

REMEDIES

 

	4.1	Each
    Party acknowledges and agrees that monetary damages would not be a sufficient remedy for the Corporation in respect of any breach
    (or threatened breach) of this Agreement and that, in the event of any breach or threatened breach by the Designating Shareholders
    or the Observer: (a) the Corporation shall have the right to immediate injunctive and other equitable relief, without proof of actual
    damages; (b) the Designating Shareholders and the Observer will not plead in defense thereof that there would be an adequate remedy
    at law; and (c) the Designating Shareholders and the Observer agree to waive any applicable right or requirement that a bond or other
    security be posted by the Corporation as a condition to obtaining any such injunctive or equitable relief. Such remedies will not
    be the exclusive remedies of the Corporation for a breach of this Agreement but will be in addition to all other remedies that may
    be available to the Corporation at law or in equity.

 

    	4

    	 

    

 

ARTICLE
5

TERMINATION

 

	5.1	This
    Agreement, together with the Acknowledgment, shall immediately terminate and be of no further force and effect on the later of (i)
    the day that is 12 months from the effective date of this Agreement and (ii) the day that the Designating Shareholders collectively
    cease to own or exercise control or direction over four percent (4%) or more of the Corporation’s outstanding Common Shares,
    provided that the provisions of Article 2 to Article 6, inclusive, shall indefinitely survive any such termination
    or expiration. Notwithstanding the foregoing, the parties may by mutual written agreement elect to extend the term of this Agreement,
    together with the Acknowledgment, for additional 12 month periods.

 

ARTICLE
6

GENERAL
PROVISIONS

 

	6.1	This
    Agreement, together with any other confidentiality or non- disclosure agreement entered into by the Designating Shareholders and/or
    the Observer with the Corporation, constitutes the entire agreement and understanding of the Parties in respect of the subject matter
    and supersedes any and all previous agreements and understandings, whether oral or written, between the Parties regarding the matters
    set out herein. For greater certainty, the Parties hereby agree that the confidentiality provisions afforded to the Confidential
    Information of the Corporation and granted in favour of the Corporation in this Agreement are intended to be in addition to any other
    confidentiality provisions afforded to the Confidential Information of the Corporation and granted in favour of the Corporation by
    the Designating Shareholders and/or the Observer in any other agreement that they have or may enter into.
	 	 
	6.2	No
    provision of this Agreement may be amended, modified or waived, except in writing signed by the Parties hereto.
	 	 
	6.3	This
    Agreement may not be assigned by the Designating Shareholders or the Observer.
	 	 
	6.4	The
    invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision,
    and if any restriction in this Agreement is found by a court to be unreasonable or unenforceable, then such court may amend or modify
    the restriction so it can be enforced to the fullest extent permitted by law.
	 	 
	6.5	The
    section headings in this Agreement have been inserted as a matter of convenience of reference and are not a part of this Agreement.
	 	 
	6.6	Any
    waiver by any Party hereto of a breach of any provision of this Agreement shall not operate or be construed to be a waiver of any
    other breach of such provision or of any breach of any other provision of this Agreement. The failure of a Party to insist on strict
    adherence to any term of this Agreement on one or more occasions shall not be construed as a waiver or deprive such Party of the
    right to thereafter insist on strict adherence to that term or any other term of this Agreement.
	 	 
	6.7	This
    Agreement may be executed in one or more counterparts, including counterparts executed by way of electronic signature, each of which
    so executed shall constitute an original and all of which together shall constitute one and the same agreement. The Parties shall
    be entitled to rely on delivery of a copy delivered by facsimile or other means of electronic transmission of the executed Agreement
    and such electronically transmitted or facsimile copy shall be legally effective to create a valid and binding agreement. In the
    event an individual executes this Agreement using DocuSign or a similar application, the signature of such individual shall not require
    a witness. Notwithstanding the date that each Party executes this Agreement, this Agreement will be deemed to have been executed
    effective as of the Effective Date.
	 	 
	6.8	This
    Agreement and the rights and obligations of the Parties under this Agreement shall be governed by and construed in accordance with
    the laws of the Province of Alberta and the laws of Canada applicable therein.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK. EXECUTION PAGE FOLLOWS.]

 

    	5

    	 

    

 

IN
WITNESS WHEREOF the Parties hereto have executed this Agreement as of the Effective Date.

 

	 	
	 	SAMUEL TULLMAN
	 	 	 
	 	 
	 	GLEN TULLMAN
	 	 	 
	 	LEIIO WELLNESS LTD.
	 	 	 
	 	Per:	
	 	Name:	Cory
    Rosenberg
	 	Title:	President
    and CEO

 

    	6

    	 

    

 

 

    	7

    	 

    

 

EXHIBIT
A

 

ACKNOWLEDGEMENT
AND AGREEMENT

 

This
Acknowledgement and Agreement (the Acknowledgement ) made effective July 14, 2021 is entered into by the undersigned as a representative
designated by the Designating Shareholders to act as the Observer under a board observer agreement entered into among Leiio Wellness
Ltd. (the Corporation), the Observer and the Designating Shareholders dated effective July 14, 2021 (the Agreement). Capitalized
terms used, but not defined, herein have the meanings ascribed thereto in the Agreement.

 

	1.	The
    undersigned hereby acknowledges and agrees:

 

	 	(a)	that
    the undersigned’s execution of this Acknowledgement is a condition precedent to the undersigned’s appointment as the
    Observer under the Agreement and the effectiveness of the rights of the Observer arising under the Agreement;
	 	 	 
	 	(b)	to
    treat any Confidential Information obtained by the undersigned from the Corporation (or any director, officer, employee or agent
    thereof) in confidence strictly in accordance with the provisions of Article 2 of the Agreement and to otherwise comply with
    and observe all of the terms and conditions of the Agreement at all times;
	 	 	 
	 	(c)	that
    the Designating Shareholders or the undersigned may terminate the undersigned’s service as the Observer at any time, with or
    without cause, in accordance with Section 1.2 and Section 5 of the Agreement; and
	 	 	 
	 	(d)	if
    the undersigned ceases to serve as the Observer, the undersigned shall:

 

	 	 	(i)	no
    longer be entitled to exercise any of the rights afforded to the Observer under the Agreement; and
	 	 	 	 
	 	 	(ii)	as
    promptly as practicable (but in any event not later than 5 business days thereafter) deliver all physical materials containing or
    consisting of Confidential Information in the undersigned’s possession or control to the Corporation and execute and deliver
    to the Corporation a certificate, in form and substance satisfactory to the Corporation acting reasonably, that the undersigned has
    delivered all such physical materials containing or consisting of the Confidential Information to the Corporation.

 

	2.	Upon
    the written request of the Corporation, the undersigned will promptly execute and deliver any and all further instruments and documents
    and take such further action as the Corporation, acting reasonably, deems necessary to effect the purposes of this Acknowledgement.
	 	 
	3.	No
    provision of this Acknowledgement may be amended, modified or waived, except in writing signed by the undersigned and the Corporation.
	 	 
	4.	The
    invalidity or unenforceability of any provision of this Acknowledgement shall not affect the validity or enforceability of any other
    provision, and, if any restriction in this Acknowledgement is found by a court to be unreasonable or unenforceable, then such court
    may amend or modify the restriction so it can be enforced to the maximum extent permitted by law.
	 	 
	5.	This
    Acknowledgement may be executed by electronic signature in any number of counterparts, each of which together shall constitute one
    and the same instrument.

 

    	8

    	 

    

 

	6.	The
    undersigned acknowledges and agrees that:
	 	 	 
	 	(a)	monetary
    damages would not be a sufficient remedy for any breach (or threatened breach) of this Agreement by the undersigned and that, in
    the event of any breach or threatened breach, the Corporation shall have the right to immediate injunctive or other equitable relief,
    without proof of actual damages;
	 	 	 
	 	(b)	the
    undersigned will not plead in defense thereto that there would be an adequate remedy at law; and
	 	 	 
	 	(c)	the
    undersigned agrees to waive any applicable right or requirement that a bond or other security be posted by the Corporation as a condition
    to the grant of such injunctive or other equitable relief.

 

The
undersigned acknowledges and agrees that the remedies in this Section 6 will not be the exclusive remedies of the Corporation
for a breach of this Agreement but will be in addition to all other remedies that may be available to the Corporation at law or in equity.

 

	7.	This
    Acknowledgment and the rights and obligations of the Parties under this Acknowledgment shall be governed by and construed in accordance
    with the laws of the Province of Alberta and the laws of Canada applicable therein.

 

IN
WITNESS WHEREOF, the undersigned has executed this Acknowledgement as of the date first written above.

 

	 	
	 	SAMUEL TULLMAN
	 	 	 
	 	Address:	1916
    17th Ave S., Seattle, WA 98144
	 	 	 
	 	Email:	samatullman@gmail.com
	 	 	 
	ACKNOWLEDGED AND ACCEPTED effective as of July 14, 2021:
	 	 	 
	 	LEIIO WELLNESS LTD.
	 	 	 
	 	Per:	
	 	Name:	Cory
    Rosenberg
	 	Title:	President
    and CEO

 

    	9Exhibit
10.10

 

EMPLOYMENT
AGREEMENT

 

BY
AND BETWEEN

 

FIRST
PERSON, INC.

AND

CORY
ROSENBERG

 

This
Employment Agreement (this “Agreement”) is entered into as of January 1, 2022 (the “Effective Date”),
by and between First Person, Inc., a Delaware corporation (the “Company”), and Cory Rosenberg (the “Executive”).

 

WHEREAS,
the Company desires to enter into a new agreement embodying the terms of the Executive’s continued employment with the Company
as its Chief Executive Officer; and

 

WHEREAS,
the Executive desires to continue employment with the Company, subject to the terms and conditions set forth in this Agreement.

 

NOW,
THEREFORE, in consideration of the premises and mutual covenants contained herein, and for other valuable consideration, the Company
and the Executive hereby agree as follows:

 

1. Certain
Definitions. Capitalized terms shall have the meanings set forth on Exhibit A attached hereto and incorporated into this
Agreement by reference.

 

2. Term
of Employment. This Agreement shall become effective and the Executive’s employment with the Company shall commence hereunder
as of the Effective Date and this Agreement shall remain in effect until the Executive’s employment with the Company is terminated
pursuant to Section 6 of this Agreement (the “Term of Employment”).

 

 3. Executive’s Duties and Obligations.

 

(a) Duties.
The Executive shall serve as the Company’s Chief Executive Officer. The Executive shall be responsible for all powers and duties
customarily associated with that office or position in a publicly-traded company. The Executive shall report directly to the Board and
shall be subject to reasonable policies established by the Company and the Parent Company.

 

(b) Location
of Employment. The Executive’s principal place of business shall be at the Executive’s office in Burbank, California.
In addition, the Executive acknowledges and agrees that the performance by the Executive of the Executive’s duties shall require
frequent travel from time to time.

 

(c) Confidentiality
and Assignment Agreement. In consideration of the covenants contained herein, the Executive shall execute concurrently with the execution
of this Agreement, and agrees to be bound by, that certain Employee Confidentiality and Assignment Agreement (the “Confidentiality
Agreement”) attached to this Agreement as Exhibit B and incorporated into this Agreement by reference. The Executive
shall comply at all times with the covenants (including, without limitation, covenants not to compete and not to solicit employees) and
other terms and conditions of the Confidentiality Agreement and all other reasonable policies of the Company governing the confidentiality
and assignment of the Company’s proprietary information. The Executive’s obligations under the Confidentiality Agreement
shall survive the Term of Employment.

 

    	-1-

     

    

 

4.
Devotion of Time to the Company’s Business.

 

(a) Full-Time
Efforts. During the Term of Employment, the Executive shall devote substantially all of his business time, attention and effort to
the affairs of the Company, excluding any periods of disability, vacation, or sick leave to which the Executive is entitled, and shall
use his reasonable best efforts to perform the duties properly assigned to him hereunder and to promote the interests of the Company.

 

(b) Other
Activities. The Executive may serve on corporate, civic, or charitable boards or committees with the prior approval of the Board,
deliver lectures, fulfill speaking engagements, and may manage personal investments that do not give rise to a conflict of interest through
the Executive’s investment in direct competitors of the Company; provided that such activities do not individually or in the aggregate
significantly interfere with the performance of his duties under this Agreement. The Executive’s passive investment in securities
of a publicly-held company will not be considered to give rise to a conflict of interest if the Executive owns not more than 5% of the
outstanding securities of such publicly-held company.

 

5.
Compensation and Benefits.

 

(a) Base
Salary. The Company shall pay to the Executive in accordance with its normal payroll practices (but not less frequently than monthly)
an annual salary at a rate of not less than $150,000 per annum (“Base Salary”). The Executive’s Base Salary
shall be reviewed at least annually for the purposes of determining increases, if any, based on the Executive’s performance, the
performance of the Company, the then-prevailing salary scales for comparable positions, inflation, and other relevant factors. Effective
as of the date of any increase in the Executive’s Base Salary, Base Salary as so increased shall be considered the new Base Salary
for all purposes of this Agreement. The Company may not reduce the Executive’s Base Salary (after taking into account any increase
in Base Salary) without the Executive’s consent unless the Company reduces the annual base salary of all members of the Company’s
senior management team on a substantially equivalent basis.

 

(b) Cash
Bonuses. In addition to Base Salary, for each full Fiscal Year during the Term of Employment, the Executive shall be eligible to
earn an annual cash bonus (“Annual Bonus”) in accordance with the terms hereof and the terms of any annual cash bonus
incentive plan maintained for the Company’s key executive officers, as amended from time to time (the “Cash Bonus Plan”).
Except as provided in Section 6 of this Agreement, the Executive will not be eligible to receive an Annual Bonus for a Fiscal
Year unless the Executive remains in continuous employment with the Company through the date on which such Annual Bonus is paid. During
the first quarter of each Fiscal Year, the Compensation Committee, in consultation with the Board, shall establish threshold, target,
and maximum performance goals for such Fiscal Year in accordance with the terms of the Cash Bonus Plan. If the target performance goals
for a Fiscal Year are attained, then the Annual Bonus for such Fiscal Year shall be not less than 20% of the Executive’s Base Salary
and if the maximum performance goals for a Fiscal Year are attained, the Annual Bonus for such Fiscal Year shall be equal to 100% of
the Executive’s Base Salary, unless the Compensation Committee (with approval from the Board) determines extraordinary circumstances
justify a larger Annual Bonus. At the conclusion of the Fiscal Year the Compensation Committee will review performance relative to the
performance goals and if the Compensation Committee determines that the Executive has earned an Annual Bonus for a Fiscal Year, the Company
will pay the Annual Bonus to the Executive on or before March 15 of the year following the end of the year for which the Annual Bonus
is earned.

 

    	-2-

     

    

 

(c) Equity
Awards. The Executive shall be eligible to receive grants of Equity Awards each year pursuant to any long-term incentive plan or
plans that may be established by the Company’s Parent Company for its senior executive employees, as may be amended from time to
time. The type of Equity Awards, vesting conditions, and the number of shares of the common stock subject to such annual grant of Equity
Awards shall be determined by the Compensation Committee in its sole discretion.

 

(d) Benefits.
During the Term of Employment, the Executive shall be entitled to participate in all employee benefit plans, programs and arrangements
made available generally to the Company’s senior executives or to other full-time employees on substantially the same basis that
such benefits are provided to such senior executives of a similar level or to other full-time employees (including, without limitation
profit-sharing, savings and other retirement plans or programs (e.g., a 401(k) plan), long-term cash incentive plan, program,
or arrangement, medical, dental, hospitalization, vision, short-term and long-term disability, and life insurance plans or programs,
accidental death and dismemberment protection, travel accident insurance, and any other fringe benefit or employee welfare benefit plans
or programs that may be sponsored by the Company from time to time, including any plans or programs that supplement the above-listed
types of plans or programs, whether funded or unfunded); provided, however, that during the Term of Employment, the Executive shall not
be eligible to participate in any generally available severance benefit plan, program, or arrangement sponsored or maintained by the
Company. Nothing in this Section 5(d) of this Agreement shall be construed to require the Company to establish or maintain any
such fringe or employee benefit plans, programs, or arrangements and the Company reserves the right to amend, modify, or terminate any
such fringe or employee benefit plan.

 

(e) Vacations.
During the Term of Employment, the Executive shall be entitled to up to six (6) weeks paid vacation each calendar year (up to one (1)
week of which may be carried forward to a succeeding year), or such greater amount as may be earned under the Company’s standard
vacation policy in effect from time to time.

 

(f) Reimbursement
of Expenses. During the Term of Employment, the Executive shall be entitled to receive prompt reimbursement for all reasonable business-or
employment-related expenses incurred by the Executive upon the receipt by the Company of reasonable documentation in accordance with
standard practices, policies, and procedures applicable to other senior executives of the Company or the Parent Company.

 

6.
Termination of Employment. The Term of Employment shall be automatically terminated upon the first to occur of the following:

 

(a) Death.
The Executive’s employment shall terminate immediately upon the Executive’s death.

 

(b) Disability.
If the Executive is Disabled, the Company may terminate the Executive’s employment due to such Disability upon delivery of written
notice to the Executive. The effective date of such termination of employment will be the Date of Termination set forth in such written
notice or immediately upon delivery of such written notice if no effective date is specified in the written notice. For avoidance of
doubt, if the Executive’s employment is terminated pursuant to this Section 6(b), his employment will not constitute a termination
of employment by the Company without Cause.

 

    	-3-

     

    

 

(c) Termination
by the Executive Without Good Reason. The Executive may terminate his employment for any reason other than Good Reason upon his delivery
of written notice to the Company at least thirty (30) days prior to his Date of Termination.

 

(d) Termination
by the Executive for Good Reason. The Executive may terminate his employment for Good Reason if (i) not later than ninety (90) days
after the occurrence of any act or omission that constitutes Good Reason, the Executive provides the Company with a written notice setting
forth in reasonable detail the acts or omissions that constitute Good Reason, (ii) the Company fails to correct or cure the acts or omissions
within thirty (30) days after it receives such written notice, and (iii) the Executive terminates his employment with the Company after
the expiration of such cure period but not later than sixty (60) days after the expiration of such cure period.

 

(e) Termination
by the Company Without Cause. The Company may terminate the Executive’s employment without Cause upon delivery of written notice
to the Executive at least thirty (30) days prior to the Date of Termination.

 

(f) Termination
by the Company for Cause. Upon the occurrence of any act or omission that constitutes Cause, the Company may terminate the Executive’s
employment if (i) no fewer than fifteen (15) days prior to the Date of Termination, the Company provides the Executive with written notice
(the “Notice of Consideration”) of its intent to consider termination of the Executive’s employment for Cause,
including a reasonably detailed description of the acts or omissions that the Board believes constitute Cause; and (ii) the Executive
fails to cure the acts or omissions that constitute Cause within fifteen (15) days after receiving such Notice of Consideration.

 

7.
Compensation and Benefits Payable Upon of Termination of Employment.

 

(a) Payment
of Accrued But Unpaid Compensation and Benefits. Upon the Executive’s termination of employment for any reason, the Executive
(or his estate following the Executive’s death) shall receive (i) a lump sum payment on the Date of Termination in an amount equal
to the sum of the Executive’s earned but unpaid Base Salary through his Date of Termination plus his accrued but unused vacation
days at the Executive’s Base Salary in effect as of his Date of Termination; plus (ii) any other benefits or rights the Executive
has accrued or earned through his Date of Termination in accordance with the terms of the applicable fringe or employee benefit plans
and programs of the Company (including any vested rights the Executive may have to outstanding Equity Awards pursuant to the terms of
such Equity Awards). Except as provided in Section 7(b) or (c) below or as expressly provided pursuant to the terms of
any employee benefit plan, the Executive will not be entitled to earn or accrue any additional compensation or benefits for any period
following his Date of Termination.

 

(b) Termination
of Employment Due to Death or Disability. In addition to the compensation and benefits payable under Section 7(a) above, if
the Executive’s employment is terminated due to his death or Disability, the Executive (or his estate following the Executive’s
death) shall receive the Executive’s accrued but unpaid Annual Bonus, if any, for the Fiscal Year ended prior to his Termination
Date payable at the same time such annual bonuses for such Fiscal Year are paid to other key executives of the Company pursuant to the
terms of the Cash Bonus Plan;

 

    	-4-

     

    

 

(c) Termination
of Employment by the Company without Cause or by the Executive for Good Reason. In addition to the compensation and benefits payable
under Section 7(a) above, if the Executive’s employment is terminated (i) by the Company without Cause, or (ii) by the Executive
for Good Reason and the Executive returns an executed Release to the Company, which becomes final, binding and irrevocable within sixty
(60) days following the Executive’s Date of Termination in accordance with Section 8 of this Agreement, then the Executive
(or his estate following the Executive’s death) shall receive:

 

	 	(i)	the
    Executive’s accrued but unpaid Annual Bonus, if any, for the Fiscal Year ended prior to his Termination Date payable at the
    same time annual bonuses for such Fiscal Year are paid to other key executives of the Company pursuant to the terms of the Cash Bonus
    Plan;
	 	 	 
	 	(ii)	the
    Annual Bonus, if any, payable for the Fiscal Year in which the Executive’s employment is terminated based on actual Fiscal
    Year performance (pro-rated for the period of employment during such Fiscal Year through the Date of Termination) payable at the
    same time annual bonuses for such Fiscal Year are paid to other key executives of the Company pursuant to the terms of the Cash Bonus
    Plan;
	 	 	 
	 	(iii)	if
    the Executive’s Date of Termination does not occur during the Post-Change of Control Period:

 

	 	(a)	A
    lump sum payment upon his Date of Termination in an amount equal to the sum of (I) twenty-four (24) months of the Executive’s
    Base Salary in effect as of his Date of Termination (without regard to any reduction in Base Salary that constitutes Good Reason),
    and (II) the amount equal to the product of two (2) times the average Annual Bonus earned by the Executive for the three (3) most
    recent complete Fiscal Years preceding the Date of Termination; provided, however, if the Date of Termination occurs prior to the
    completion of three (3) full Fiscal Years in which the Executive was eligible for an Annual Bonus, then the amount shall be determined
    on the basis of the number of Fiscal Years completed at that time;
	 	 	 
	 	(b)	reimbursement
    of the COBRA premiums, if any, paid by the Executive for continuation coverage for the Executive, his spouse and eligible dependents
    under the Company’s group health, dental, and vision plans for the lesser of twelve (12) months or the maximum COBRA continuation
    period; and

 

    	-5-

     

    

 

	 	(iv)	if
    the Executive’s Date of Termination occurs during the Post-Change of Control Period:

 

	 	(a)	A
    lump sum payment upon his Date of Termination in an amount equal to the sum of (I) twenty-four (24) months of the Executive’s
    Base Salary in effect as of his Date of Termination (without regard to any reduction in Base Salary that constitutes Good Reason),
    and (II) the amount equal to the product of two (2) times the average Annual Bonus earned by the Executive for the three (3) most
    recent complete Fiscal Years preceding the Date of Termination; provided, however, if the Date of Termination occurs prior to the
    completion of three (3) full Fiscal Years in which the Executive was eligible for an Annual Bonus, then the amount shall be determined
    on the basis of the number of Fiscal Years completed at that time; and
	 	 	 
	 	(b)	reimbursement
    of the COBRA premiums, if any, paid by the Executive for continuation coverage for the Executive, his spouse and eligible dependents
    under the Company’s group health, dental and vision plans for the lesser of eighteen (18) months or the maximum COBRA continuation
    period; and
	 	 	 
	 	(c)	the
    status of the Executive’s outstanding Equity Awards will be determined in accordance with the long-term incentive plan in effect
    on the Date of Termination.

 

Notwithstanding
the foregoing, no payment that is otherwise required to be paid to the Executive pursuant to this Section 7(c) before the Release
becomes final, binding and irrevocable, shall be paid to the Executive until his Release becomes final, binding and irrevocable. In addition,
if the Executive materially breaches this Agreement or the Executive’s Confidentiality Agreement, then the Company’s continuing
obligations under this Section 7(c) shall cease as of the date of the breach and the Executive shall be entitled to no further
payments hereunder.

 

8.
Release. As a condition of receiving the compensation and benefits described in Section 7(c) of this Agreement, the
Executive must execute a general waiver and release of any and all claims against the Company, the Parent Company, and their respective
shareholders, officers, directors, employees, and agents, arising out of the Executive’s employment with the Company or the Executive’s
separation from such employment (including, without limitation, claims relating to age, disability, sex, or race discrimination to the
extent permitted by law), excepting (i) claims based on breach of the Company’s obligations to pay the compensation and benefits
described in Sections 5 or 7 of this Agreement, (ii) claims arising under the Age Discrimination in Employment Act after
the date the Executive signs such release, and (iii) any right to indemnification by the Company or to coverage under directors and officers
liability insurance to which the Executive is otherwise entitled in accordance with this Agreement and the Company’s Certificate
of Incorporation or Bylaws or other agreement between the Executive and the Company (the “Release”). Such Release
shall be in a form tendered to the Executive by the Company within five (5) business days following the termination of the Executive’s
employment by the Company without Cause or by the Executive for Good Reason, which shall comply with any applicable legislation or judicial
requirements, including, but not limited to, the Older Workers Benefit Protection Act. The compensation and benefits described in Section
7(c) of this Agreement will not be paid to the Executive if the Executive fails to execute the Release within the time frame specified
in such Release, if the Executive revokes the Release within the applicable revocation period set forth in such Release, or if the Release
does not become final, binding, and irrevocable within sixty (60) days following the Executive’s Date of Termination.

 

    	-6-

     

    

 

9.
Mitigation of Damages. The Executive will not be required to mitigate damages or the amount of any payment or benefit provided
for under this Agreement by seeking other employment or otherwise. The amount of any payment or benefit provided for under this Agreement
will not be reduced by any compensation or benefits earned by the Executive as the result of self-employment or employment by another
employer or otherwise.

 

10.
Notices. All notices, requests, demands, and other communications hereunder shall be in writing and shall be deemed to have
been duly given if delivered by hand, email, or mailed within the continental United States by first class certified mail, return receipt
requested, postage prepaid, addressed as follows:

 

If
to the Board or the Company:

 

First
Person, Inc.

Attention:
Jan Campbell

Suite
1840, 444 – 5 Ave SW

Calgary,
AB, T2P 2T8

jcampbell@complyinc.ca

 

If
to the Executive:

 

To
the address on file with the records of the Company.

 

Addresses
may be changed by written notice sent to the other party at the last recorded address of that party.

 

11. Withholding.
The Company shall be entitled to withhold from payments due hereunder any required federal, state, or local withholding or other
taxes.

 

12.
Arbitration.

 

(a) If
the parties are unable to resolve any dispute or claim relating directly or indirectly to this Agreement, the Confidentiality Agreement,
or any dispute or claim between the Executive and the Company, the Parent Company and any of their subsidiaries or any of their respective
officers, directors, agents, or employees (a “Dispute”), then either party may require the matter to be settled by
final and binding arbitration by sending written notice of such election to the other party clearly marked “Arbitration Demand.”
Thereupon such Dispute shall be arbitrated in accordance with the terms and conditions of this Section 12. Notwithstanding the
foregoing, either party may apply to a court of competent jurisdiction for a temporary restraining order, a preliminary injunction, or
other equitable relief to preserve the status quo or prevent irreparable harm or to enforce the terms of the Confidentiality Agreement.

 

(b) The
Dispute shall be resolved by a single arbitrator in an arbitration administered by the Judicial Arbitration & Mediation Services,
Inc. (“JAMS”), pursuant to its Employment Arbitration Rules and Procedures (the “JAMS Rules”) judgment
upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The decision of the arbitrator shall
be final and binding on the parties, and specific performance giving effect to the decision of the arbitrator may be ordered by any court
of competent jurisdiction.

 

(c) Nothing
contained herein shall operate to prevent either party from asserting counterclaim(s) in any arbitration commenced in accordance with
this Agreement, and any such party need not comply with the procedural provisions of this Section 12 in order to assert such counterclaim(s).

 

    	-7-

     

    

 

(d) The
arbitration shall be filed with the office of the JAMS located in California or such other JAMS office as the parties may agree upon
(without any obligation to so agree). The arbitration shall be conducted pursuant to the JAMS Rules as in effect at the time of the arbitration
hearing. In addition, the following rules and procedures shall apply to the arbitration:

 

	 	(i)	The
    arbitrator shall have the sole authority to decide whether or not any Dispute between the parties is arbitrable and whether the party
    presenting the issues to be arbitrated has satisfied the conditions precedent to such party’s right to commence arbitration
    as required by this Section 12.
	 	 	 
	 	(ii)	The
    decision of the arbitrator, which shall be in writing and state the findings, the facts and conclusions of law upon which the decision
    is based, shall be final and binding upon the parties, who shall forthwith comply after receipt thereof. Judgment upon the award
    rendered by the arbitrator may be entered by any competent court. Each party submits itself to the jurisdiction of any such court,
    but only for the entry and enforcement to judgment with respect to the decision of the arbitrator hereunder.
	 	 	 
	 	(iii)	The
    arbitrator shall have the power to grant all legal and equitable remedies (including, without limitation, specific performance) and
    award compensatory and punitive damages if authorized by applicable law.
	 	 	 
	 	(iv)	If
    the Executive commences the arbitration, he will only be required to pay the cost equivalent to filing a legal action in a court
    of competent jurisdiction; the Company shall be responsible for the balance of the costs. The prevailing party in any arbitration
    shall be entitled to their reasonable attorneys’ fees and expenses.
	 	 	 
	 	(v)	Except
    as provided in the last sentence of Section 12(a) above, the provisions of this Section 12 shall be a complete defense
    to any suit, action or proceeding instituted in any federal, state, or local court or before any administrative tribunal with respect
    to any Dispute arising in connection with this Agreement. Any party commencing a lawsuit in violation of this Section 12 shall
    pay the costs of the other party, including, without limitation, reasonable attorney’s fees and defense costs.

 

 13. Miscellaneous.

 

(a) Governing
Law. This Agreement shall be interpreted, construed, governed and enforced according to the laws of the State of California without
regard to the application of choice of law rules.

 

(b) Entire
Agreement. This Agreement, together with the Exhibits attached hereto, contains the entire agreement between the parties with respect
to the subject matter hereof and supersedes any and all other prior agreements, promises, understandings and representations regarding
the Executive’s employment, compensation, severance, or other payments contingent upon the Executive’s termination of employment,
whether written or otherwise.

 

    	-8-

     

    

 

(c) Amendments.
No amendment or modification of the terms or conditions of this Agreement shall be valid unless in writing and signed by the parties
hereto.

 

(d) Severability.
If one or more provisions of this Agreement are held to be invalid or unenforceable under applicable law, such provisions shall be construed,
if possible, so as to be enforceable under applicable law, or such provisions shall be excluded from this Agreement and the balance of
this Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.

 

(e) Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the beneficiaries, heirs and representatives of the Executive
and the successors and assigns of the Company. This Agreement shall be binding upon any successor of the Company in accordance with the
operation of law and such successor shall be deemed the Company for purposes of this Agreement.

 

(f) Successors
and Assigns; Nonalienation of Benefits. Except as provided in Section 13(e) above, in the case of the Company, or to the Executive’s
estate and heirs in the case of the death of the Executive, this Agreement is not assignable by any party. Compensation and benefits
payable to the Executive under this Agreement shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment,
pledge, encumbrance, charge, garnishment, execution, or levy of any kind, either voluntary or involuntary, prior to actually being received
by the Executive or his estate, as applicable, and any such attempt to dispose of any right to benefits payable hereunder shall be void,
and no payment to be made hereunder shall be subject to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, or
other charge.

 

(g) Remedies
Cumulative; No Waiver. No remedy conferred upon either party by this Agreement is intended to be exclusive of any other remedy, and
each and every such remedy shall be cumulative and shall be in addition to any other remedy given hereunder or now or hereafter existing
at law or in equity. No delay or omission by either party in exercising any right, remedy or power hereunder or existing at law or in
equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such party from time to time and
as often as may be deemed expedient or necessary by such party in such party’s sole discretion.

 

(h) Survivorship.
Notwithstanding anything in this Agreement to the contrary, all terms and provisions of this Agreement that by their nature extend beyond
the Date of Termination shall survive termination of this Agreement.

 

(i) Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken
together, shall constitute one document.

 

 14. Code Section 409A.

 

(a) The
intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Code Section 409A and, accordingly,
to the maximum extent permitted, this Agreement shall be construed and interpreted in accordance with such intent. The Executive’s
termination of employment (or words to similar effect) shall not be deemed to have occurred for purposes of this Agreement unless such
termination of employment constitutes a “separation from service” within the meaning of Code Section 409A and the regulations
and other guidance promulgated thereunder.

 

    	-9-

     

    

 

(b) Notwithstanding
any provision in this Agreement to the contrary, if the Executive is deemed on the date of the Executive’s separation from service
to be a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B) and using the identification
methodology selected by the Company from time to time, or if none, the default methodology set forth in Code Section 409A, then with
regard to any payment or any benefit that constitutes “non-qualified deferred compensation” pursuant to Code Section 409A
and the regulations issued thereunder that is payable due to the Executive’s separation from service, to the extent required to
be delayed in compliance with Code Section 409A(a)(2)(B), such payment or benefit shall not be made or provided to the Executive prior
to the earlier of (i) the expiration of the six (6)-month period measured from the date of the Executive’s separation from service,
and (ii) the date of the Executive’s death (the “Delay Period”). On the first day of the seventh month following
the date of the Executive’s separation from service or, if earlier, on the date of the Executive’s death, all payments delayed
pursuant to this Section 14 shall be paid or reimbursed to the Executive in a lump sum, and any remaining payments and benefits
due to the Executive under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein.

 

(c) To
the extent any reimbursement of costs and expenses (including reimbursement of COBRA premiums pursuant to Section 7(c) of this
Agreement) provided for under this Agreement constitutes taxable income to the Executive for Federal income tax purposes, such reimbursements
shall be made as soon as practicable after the Executive provides proper documentation supporting reimbursement but in no event later
than December 31 of the calendar year next following the calendar year in which the expenses to be reimbursed are incurred. With regard
to any provision herein that provides for reimbursement of expenses or in-kind benefits, except as permitted by Code Section 409A, (i)
the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit, and (ii) the amount of
expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for
reimbursement, or in-kind benefits to be provided, in any other taxable year.

 

(d) If
under this Agreement, any amount is to be paid in two or more installments, each such installment shall be treated as a separate payment
for purposes of Code Section 409A.

 

    	-10-

     

    

 

 15. Excess Parachute Excise Tax.

 

(a) Anything
in this Agreement to the contrary notwithstanding, in the event it shall be determined that any payment, award, benefit or distribution
(including any acceleration) by the Company or any entity which effectuates a transaction described in Code Section 280G(b)(2)(A)(i)
to or for the benefit of the Executive (whether pursuant to the terms of this Agreement or otherwise, but determined before application
of any reductions required pursuant to this Section 15) (a “Payment”) would be subject to the excise tax imposed
by Code Section 4999 or any interest or penalties are incurred with respect to such excise tax by the Executive (such excise tax, together
with any such interest and penalties, are hereinafter collectively referred to as the “Excise Tax”), the Company will
automatically reduce such Payments to the extent, but only to the extent, necessary so that no portion of the remaining Payments will
be subject to the Excise Tax, unless the amount of such Payments that the Executive would retain after payment of the Excise Tax and
all applicable Federal, state and local income taxes without such reduction would exceed the amount of such Payments that the Executive
would retain after payment of all applicable Federal, state, and local taxes after applying such reduction. Unless otherwise elected
by the Executive, to the extent permitted under Code Section 409A, such reduction shall first be applied to any severance payments payable
to the Executive under this Agreement, then to the accelerated vesting on any Equity Awards, starting with stock options and stock appreciation
rights reversing accelerated vesting of those options and stock appreciation rights with the highest exercise price first and after reversing
the accelerated vesting of all stock options and stock appreciation rights, thereafter reversing accelerated vesting of restricted stock,
restricted stock units, and performance shares, performance units, or other similar Equity Awards on a pro rata basis.

 

(b) All
determinations required to be made under this Section 15, including the assumptions to be utilized in arriving at such determination,
shall be made by the Company’s independent auditors or such other certified public accounting firm of national standing reasonably
acceptable to the Executive as may be designated by the Company (the “Accounting Firm”) which shall provide detailed
supporting calculations both to the Company and the Executive within fifteen (15) business days of the receipt of notice from the Executive
that there has been a Payment, or such earlier time as is requested by either the Company or the Executive. All fees and expenses of
the Accounting Firm shall be borne solely by the Company. If the Accounting Firm determines that no Excise Tax is payable by the Executive,
it shall furnish the Executive with a written opinion to such effect. Any determination by the Accounting Firm shall be binding upon
the Company and the Executive.

 

16. Executive
Acknowledgement. The Executive hereby acknowledges that the Executive has read and understands the provisions of this Agreement,
that the Executive has been given the opportunity for the Executive’s legal counsel to review this Agreement, that the provisions
of this Agreement are reasonable, and that the Executive has received a copy of this Agreement.

 

[REMAINDER
OF THIS PAGE INTENTIONALLY LEFT BLANK]

 

    	-11-

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Employment Agreement to be executed on     March 23,            2022.

 

	FIRST PERSON, INC.	 
	 	 
	By:		 
	 	 	 
	Name:	Darcy
                                            Campbell

    
	 
	 	 	 
	Title:	CFO
	 

 

	EXECUTIVE	 
	 	 
	

	 
	CORY
    ROSENBERG	 

 

    	-12-

     

    

 

EXHIBIT
A

 

(a)
“Annual Bonus” shall have the meaning set forth in Section 5(b) of this Agreement.

 

(b)
“Base Salary” shall have the meaning set forth in Section 5(a) of this Agreement.

 

 (c) “Board” means the Board of Directors of the Parent Company.

 

(d)
“Cash Bonus Plan” shall have the meaning set forth in Section 5(b) of this Agreement.

 

(e) “Cause” means one or more of the following:

 

	 	(i)	The
    Executive’s willful and continuous failure to perform his essential duties hereunder or the lawful directives of the Board
    (other than as a result of illness or injury);
	 	 	 
	 	(ii)	The
    Executive’s willful misconduct or gross negligence in the performance of his duties hereunder that directly, the could reasonably
    be expected to materially and demonstrably impair or damage the property, goodwill, reputation, business, or finances of the Company;
	 	 	 
	 	(iii)	The
    conviction of, or plea of nolo contendere by, the Executive to a felony or a crime involving moral turpitude that could reasonably
    be expected to materially and demonstrably impair or damage the property, goodwill, reputation, business, or finances of the Company;
	 	 	 
	 	(iv)	The
    Executive’s material breach of his obligations under the Confidentiality Agreement;
	 	 	 
	 	(v)	The
    Executive’s willful material violation of the Company policies that could reasonably be expected to materially and demonstrably
    impair or damage the property, goodwill, reputation, business, or finances of the Company; or
	 	 	 
	 	(vi)	The
    Executive’s commission of any willful acts of personal dishonesty in connection with his responsibilities as an employee of
    the Company that could reasonably be expected to materially and demonstrably impair or damage the property, goodwill, reputation,
    business, or finances of the Company.

 

(f)
“Change of Control” means the occurrence of any one of the following events.

 

    	A-1

     

    

 

	 	(i)	any
    “person” (as defined in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Exchange Act”)),
    other than the Parent Company or any subsidiary of the Parent Company, any trustee or other fiduciary holding securities under an
    employee benefit plan of the Parent Company or any subsidiary of the Parent Company, an underwriter temporarily holding securities
    pursuant to an offering of such securities or any corporation owned, directly or indirectly, by the stockholders of the Parent Company
    in substantially the same proportions as their ownership of stock of the Parent Company, directly or indirectly acquires “beneficial
    ownership” (as defined in Rule 13d-3 under the Exchange Act) of securities representing more than 50% of the combined voting
    power of the Parent Company’s then outstanding securities;
	 	 	 
	 	(ii)	the
    consummation of a reorganization, merger, statutory share exchange, consolidation, or similar corporate transaction (each, a “Business
    Combination”) other than a Business Combination in which all or substantially all of the individuals and entities who were
    the beneficial owners of the Parent Company’s voting securities immediately prior to such Business Combination beneficially
    own, directly or indirectly, 50% or more of the combined voting power of the voting securities of the entity resulting from such
    Business Combination (including, without limitation, an entity which as a result of the Business Combination owns the Parent Company
    or all or substantially all of the Parent Company’s assets either directly or through one or more subsidiaries) in substantially
    the same proportions as their ownership of the Parent Company’s voting securities immediately prior to such Business Combination;
    or
	 	 	 
	 	(iii)	any
    “person” (as defined in Sections 13(d) and 14(d) of the Exchange Act) acquires all or substantially all of the assets
    of the Parent Company within any twelve (12) consecutive month period.

 

Notwithstanding
the forgoing, none of the foregoing events shall constitute a Change of Control of the Company unless such event also constitutes a change
in ownership of the Company within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(v) or a change in ownership of a substantial
portion of the assets of the Company within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(vii).

 

(g) “Change
of Control Date” means any date after the date hereof on which a Change of Control occurs.

 

(h)
“COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985.

 

(i) “Code”
means the U.S. Internal Revenue Code of 1986, as amended and the regulations promulgated thereunder.

 

(j) “Compensation
Committee” means the compensation committee of the Parent Company’s board of directors or such other committee of the
Parent Company’s board of directors that exercises the duties and responsibilities typically assigned to a compensation committee
and if no such committee has been established, the Compensation Committee shall mean the Parent Company’s full board of directors
..

 

    	A-2

     

    

 

(k) “Confidentiality
Agreement” means the Employee Confidentiality and Assignment Agreement between the Company and the Executive, a copy of which
is attached to this Agreement as Exhibit B, pursuant to which the Executive has agreed to abide by certain covenants (including
but not limited to covenants not to disclose confidential information or compete with the Company or solicit employees of the Company).

 

(l) “Date
of Termination” means the date specified in a written notice of termination delivered pursuant to Section 6 of this
Agreement, or the Executive’s last date as an active employee of the Company before a termination of employment due to his death.

 

(m) “Disabled”
or “Disability” means a mental or physical condition that renders the Executive substantially incapable of performing
his duties and obligations under this Agreement, after taking into account provisions for reasonable accommodation, as determined by
a medical doctor (such doctor to be mutually determined in good faith by the parties) for 180 days (whether or not consecutive) within
any twelve (12) consecutive month period.

 

(n) “Equity
Awards” means stock options, stock appreciation rights, restricted shares, restricted stock units, deferred stock, performance
shares or performance units or any other stock-based awards granted by the Parent Company to the Executive whether pursuant to the terms
of an equity incentive plan or otherwise.

 

(o)
“Fiscal Year” means the fiscal year of the Parent Company, which is the calendar year.

 

(p) “Good
Reason” means, unless the Executive has consented in writing thereto, the occurrence of any of the following:

 

	 	(i)	the
    assignment to the Executive of any duties materially inconsistent with the Executive’s position, including any change in status,
    title, authority, duties or responsibilities or any other action which results in a material diminution in such status, title, authority,
    duties, or responsibilities;
	 	 	 
	 	(ii)	a
    material reduction in the Executive’s Base Salary without the Executive’s consent by the Company other than a reduction
    in the annual base salary of all members of the Company’s senior management team on a substantially equivalent basis;
	 	 	 
	 	(iii)	the
    relocation of the Executive’s principal office without his written consent to a location that increases the Executive’s
    one-way commute from his residence at the time such relocation becomes effective by more than 30 minutes;
	 	 	 
	 	(iv)	any
    material reduction in the Company’s willingness or obligation to indemnify the Executive against liability for actions (or
    inaction, as the case may be) in his capacity as an officer of the Company; or
	 	 	 
	 	(v)	a
    material breach of this Agreement by the Company.

 

    	A-3

     

    

 

(q)
“Maximum Annual Bonus” shall have the meaning set forth in Section 5(b) of this Agreement.

 

(r) “Parent Company” means First Person Ltd., a company incorporated in Alberta, Canada.

 

(s) “Post-Change
of Control Period” means the period beginning on the Change of Control Date and ending 24 months after the date of the related
Change of Control.

 

 (t) “Release” shall have the meaning set forth in Section 8 of this Agreement.

 

    	A-4

     

    

 

EXHIBIT
B

 

EMPLOYEE
CONFIDENTIALITY AND ASSIGNMENT AGREEMENT

 

    	B-1

     

    

 

First
Person Inc.

Employee
Confidentiality and Assignment Agreement

 

In
consideration and as a condition of my employment or continued employment by First Person, Inc., I agree as follows:

 

1. Proprietary
Information. I agree that all information, whether or not in writing, concerning First Person, Inc. and its Affiliates’
(collectively, the “Company”) business, technology, business relationships or financial affairs which the Company has not
released to the general public (collectively, “Proprietary Information”) is and will be the exclusive property of the Company.
By way of illustration, Proprietary Information may include information or material which has not been made generally available to the
public, such as: (a) corporate information, including plans, strategies, methods, policies, resolutions, negotiations or litigation;
(b) marketing information, including strategies, methods, customer identities or other information about customers, prospect identities
or other information about prospects, or market analyses or projections; (c) financial information, including cost and performance
data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists; and (d) operational
and technological information, including plans, specifications, manuals, forms, templates, software, designs, methods, procedures,
formulas, discoveries, inventions, improvements, concepts and ideas; and (e) personnel information, including personnel lists,
reporting or organizational structure, resumes, personnel data, compensation structure, performance evaluations and termination arrangements
or documents. Proprietary Information also includes information received in confidence by the Company from its customers or suppliers
or other third parties. For purposes of this Agreement, “Affiliate” means any entity that, directly or indirectly through
one or more intermediaries, is in control of, is controlled by, or is under common control with, First Person, Inc. The term “control”
(including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly,
of the power to direct or cause the direction of an entity’s management and policies, whether through the ownership of voting securities,
by contract, or otherwise.

 

2. Recognition
of Company’s Rights. I will not, at any time, without the Company’s prior written permission, either during or after
my employment, disclose any Proprietary Information to anyone outside of the Company, or use or permit to be used any Proprietary Information
for any purpose other than the performance of my duties as an employee of the Company. I will cooperate with the Company and use my best
efforts to prevent the unauthorized disclosure of all Proprietary Information. I will deliver to the Company all copies of Proprietary
Information in my possession or control upon the earlier of a request by the Company or termination of my employment. I will not, under
any circumstances, (a) remove any source code of the Company from the premises of the Company or (b) remotely access any source code
of the Company.

 

3. Rights
of Others. I understand that the Company is now and may hereafter be subject to non-disclosure or confidentiality agreements
with third persons which require the Company to protect or refrain from use of Proprietary Information. I agree to be bound by the terms
of such agreements in the event I have access to such Proprietary Information.

 

4. Commitment
to Company; Avoidance of Conflict of Interest. While an employee of the Company, I will devote my full-time efforts to the Company’s
business and I will not engage in any other business activity that conflicts with my duties to the Company. I will advise the president
of the Company or his or her nominee at such time as any activity of either the Company or another business presents me with a conflict
of interest or the appearance of a conflict of interest as an employee of the Company. I will take whatever action is requested of me
by the Company to resolve any conflict or appearance of conflict which it finds to exist.

 

5. Developments.
I will make full and prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications,
improvements, processes, algorithms, databases, computer programs, formulae, techniques, trade secrets, ideas, concepts, methodologies,
graphics or images, and audio or visual works and other works of authorship (collectively “Developments”), whether or not
patentable or copyrightable, that are created, made, conceived or reduced to practice by me (alone or jointly with others) or under my
direction during the period of my employment. I acknowledge that all work performed by me is on a “work for hire” basis,
and I hereby do assign and transfer and, to the extent any such assignment cannot be made at present, will assign and transfer, to the
Company and its successors and assigns all my right, title and interest in all Developments that (a) relate to the business of the Company
(including any Developments that relate or could relate to the more generalized industry in which the Company operates or is proposing
to operate, whether or not it is directly applicable to the business of the Company) or any customer of the Company or any of the products
or services being researched, developed, manufactured or sold by the Company or which may be used with such products or services; or
(b) result from tasks assigned to me by the Company; or (c) result from the use of premises or personal property (whether tangible or
intangible) owned, leased or contracted for by the Company (“Company-Related Developments”), and all related patents, patent
applications, trademarks and trademark applications, copyrights and copyright applications, and other intellectual property rights in
all countries and territories worldwide and under any international conventions (“Intellectual Property Rights”).

 

    	 

     

    

 

To
preclude any possible uncertainty, I have set forth on Exhibit A attached hereto a complete list of Developments that I have,
alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of my employment with the Company
that I consider to be my property or the property of third parties and that I wish to have excluded from the scope of this Agreement
(“Prior Inventions”). If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement,
I understand that I am not to list such Prior Inventions in Exhibit A but am only to disclose a cursory name for each such invention,
a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason.
I have also listed on Exhibit A all patents and patent applications in which I am named as an inventor, other than those which
have been assigned to the Company (“Other Patent Rights”). If no such disclosure is attached, I represent that there are
no Prior Inventions or Other Patent Rights. If, in the course of my employment with the Company, I incorporate a Prior Invention into
a Company product, process or machine or other work done for the Company, I hereby grant to the Company a nonexclusive, royalty-free,
paid-up, irrevocable, worldwide license (with the full right to sublicense) to make, have made, modify, use, sell, offer for sale and
import such Prior Invention. Notwithstanding the foregoing, I will not incorporate, or permit to be incorporated, Prior Inventions in
any Company-Related Development without the Company’s prior written consent.

 

This
Agreement does not obligate me to assign to the Company any Development which, in the sole judgment of the Company, reasonably exercised,
is developed entirely on my own time and does not relate to the business efforts or research and development efforts in which, during
the period of my employment, the Company actually is engaged or reasonably would be engaged, and does not result from the use of premises
or equipment owned or leased by the Company. However, I will also promptly disclose to the Company any such Developments for the purpose
of determining whether they qualify for such exclusion. I understand that to the extent this Agreement is required to be construed in
accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions
made by an employee, this paragraph 5 will be interpreted not to apply to any invention which a court rules and/or the Company agrees
falls within such classes. I also hereby waive all claims to any moral rights or other special rights which I may have or accrue in any
Company-Related Developments.

 

6. Documents
and Other Materials. I will keep and maintain adequate and current records of all Proprietary Information and Company-Related
Developments developed by me during my employment, which records will be available to and remain the sole property of the Company at
all times.

 

All
files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification
sheets, program listings, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary
Information, whether created by me or others, which come into my custody or possession, are the exclusive property of the Company to
be used by me only in the performance of my duties for the Company. Any property situated on the Company’s premises and owned by
the Company, including without limitation computers, disks and other storage media, filing cabinets or other work areas, is subject to
inspection by the Company at any time with or without notice. In the event of the termination of my employment for any reason, I will
deliver to the Company all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts,
quotations and proposals, specification sheets, program listings, blueprints, models, prototypes, or other written, photographic or other
tangible material containing Proprietary Information, and other materials of any nature pertaining to the Proprietary Information of
the Company and to my work, and will not take or keep in my possession any of the foregoing or any copies.

 

7. Enforcement
of Intellectual Property Rights. I will cooperate fully with the Company, both during and after my employment with the Company,
with respect to the procurement, maintenance and enforcement of Intellectual Property Rights in Company-Related Developments. I will
sign, both during and after the term of this Agreement, all papers, including without limitation copyright applications, patent applications,
declarations, oaths, assignments of priority rights, and powers of attorney, which the Company may deem necessary or desirable in order
to protect its rights and interests in any Company-Related Development. If the Company is unable, after reasonable effort, to secure
my signature on any such papers, I hereby irrevocably designate and appoint each officer of the Company as my agent and attorney-in-fact
to execute any such papers on my behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect
its rights and interests in any Company-Related Development. I hereby waive and irrevocably quitclaim to the Company or its designee
any and all claims, of any nature whatsoever, which I now or hereafter have for infringement of any and all proprietary rights assigned
to the Company or such designee.

 

8. Non-Solicitation;
Non-Competition. Except as may be prohibited by law, during the Restricted Period (as defined below), I will not, directly or
indirectly, in any manner, other than for the benefit of the Company, (a) call upon, solicit, divert or take away any of the customers
or business of the Company or any of its suppliers, or request or cause any of the above to cancel or terminate any part or their relationship
with the Company or refuse to enter into any business relationship with the Company, (b) solicit, entice or attempt to persuade any employee,
agent or consultant of the Company to leave the services of the Company for any reason or take any other action that may cause any such
individual to terminate his or her employment with, or otherwise cease his or her relationship with, the Company, or assist in such hiring
or engagement by another person or business entity, and/or (c) own, operate, manage, control, engage in, participate in, invest in, permit
my name to be used by, act as a consultant or advisor to, render services for (alone or in association with any other person or entity),
or otherwise assist any person or entity that engages in or owns, invests in, operates, manages or controls any venture or enterprise
which, directly or indirectly, wholly or partly, competes with the Company’s business of supplying mushroom ingredients, producing
and selling nutraceuticals, researching psychedelic mushrooms, and developing psychedelic mushroom products, anywhere in North America.
For purposes of this Agreement, the term “Restricted Period” shall mean the period of time during which I am employed by
the Company and a period of twelve (12) months immediately following the termination of my employment with the Company. In the event
that I violate any of the provisions of this paragraph 8, I agree that the running of the Restricted Period will be extended by the time
during which I engaged in such violation(s).

 

    	2

     

    

 

9. Government
Contracts. I acknowledge that the Company may have from time to time agreements with other persons or with the United States
Government or its agencies which impose obligations or restrictions on the Company regarding inventions made during the course of work
under such agreements or regarding the confidential nature of such work. I agree to comply with any such obligations or restrictions
upon the direction of the Company. In addition to the rights assigned under paragraph 5, I also assign to the Company (or any of its
nominees) all rights which I have or acquired in any Developments, full title to which is required to be in the United States under any
contract between the Company and the United States or any of its agencies.

 

10. Prior
Agreements. I hereby represent that, except as I have fully disclosed previously in writing to the Company, I am not bound by
the terms of any agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential
or proprietary information in the course of my employment with the Company or to refrain from competing, directly or indirectly, with
the business of such previous employer or any other party. I further represent that my performance of all the terms of this Agreement
as an employee of the Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or
data acquired by me in confidence or in trust prior to my employment with the Company. I will not disclose to the Company or induce the
Company to use any confidential or proprietary information or material belonging to any previous employer or others.

 

11. Remedies
Upon Breach. I understand that the restrictions contained in this Agreement are necessary for the protection of the business
and goodwill of the Company and I consider them to be reasonable for such purpose. Any breach of this Agreement is likely to cause the
Company substantial and irrevocable damage and therefore, in the event of such breach, the Company, in addition to any other available
remedies, shall be entitled to injunctive relief without the necessity of proving actual damages.

 

12. Use
of Voice, Image and Likeness. I give the Company permission to use my voice, image or likeness, with or without using my name,
for the purposes of advertising and promoting the Company, or for other purposes deemed appropriate by the Company in its reasonable
discretion, except to the extent expressly prohibited by law.

 

13. Publications
and Public Statements. I will obtain the Company’s written approval before publishing or submitting for publication any
material that relates to my work at the Company and/or incorporates any Proprietary Information. To ensure that the Company delivers
a consistent message about its products, services and operations to the public, and further in recognition that even positive statements
may have a detrimental effect on the Company in certain securities transactions and other contexts, any statement about the Company which
I create, publish or post during my period of employment and at any time thereafter, on any media accessible by the public, including
but not limited to electronic bulletin boards and Internet-based chat rooms, must first be reviewed and approved by an officer of the
Company before it is released in the public domain.

 

14. No
Employment Obligation. I understand that this Agreement does not create an obligation on the Company or any other person to continue
my employment. I acknowledge that, unless otherwise agreed in a formal written employment agreement signed by an authorized officer of
the Company, my employment with the Company may be terminated by the Company or me at any time and for any reason.

 

15. Return
of Company Property. Upon termination of my employment with the Company, or at any time the Company requests, I will deliver
immediately to the Company, will not delete or destroy, and will not keep in my possession, recreate, or deliver to anyone else, any
and all property belonging to the Company, including any and all Proprietary Information in any form, stage or development or media,
as well as devices and equipment belonging to the Company, Company credit cards, electronic data, and any other documents and property.
I acknowledge that any of my non-work emails or information on the Company’s devises and equipment belong to the Company and I
have the right to copy such information at any time prior to termination.

 

16. Survival
and Assignment by the Company. I understand that my obligations under this Agreement will continue in accordance with its express
terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment.
I further understand that my obligations under this Agreement will continue following the termination of my employment regardless of
the manner of such termination and will be binding upon my heirs, executors and administrators. The Company will have the right to assign
this Agreement to its affiliates, successors and assigns. I expressly consent to be bound by the provisions of this Agreement for the
benefit of the Company or any parent, subsidiary or affiliate to whose employ I may be transferred without the necessity that this Agreement
be re-signed at the time of such transfer.

 

17. Disclosure
to Future Employers. I will provide a copy of this Agreement to any prospective employer, partner or coventurer prior to entering
into an employment, partnership or other business relationship with such person or entity in order to apprise such person or entity of
the restrictions hereunder this Agreement.

 

18. Severability.
In case any provisions or portions thereof contained in this Agreement shall, for any reason, be held invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement
shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein. If one or more of the provisions
contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject,
it shall be construed by limiting and reducing it, so as to be enforceable to the maximum extent permissible under applicable law.

 

19. Interpretation.
This Agreement shall in all respects be interpreted, enforced and governed under the laws of the state where I will perform or have
performed most of my services for the Company. This Agreement contains the full and complete understanding of the parties with respect
to the subject matter hereof and supersedes all prior agreements, representations, and understandings, whether oral or written, with
respect to the subject matter hereof.

 

    	3

     

    

 

I
UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. BY SIGNING BELOW, I CERTIFY THAT I HAVE READ IT CAREFULLY AND AM SATISFIED THAT
I UNDERSTAND IT COMPLETELY.

 

IN
WITNESS WHEREOF, the undersigned has executed this agreement as a sealed instrument as of the date set forth below.

 

	Signed:		
	 	(Employee’s
    full name)
    	 

 

	Type
    or print name:	Cory
    Rosenberg	 	 

                                                                     
	 	 
	Current
    Home Address:
    	11175
    Dona Pegita Drive	Date:
    	March 23	,
    2022	 
	 	Studio
City, CA 91604	 	 	 	 
	Private
E-mail Address:
    	                   corypr@gmail.com
    	 	 

 

    	 

     

    

 

EXHIBIT
A

 

	To:

		 
	 	(Company)	 
	 	 	 
	From:
    	 	 
	 	(Employee)
    	 

 

	Date:
    	 	 

 

SUBJECT: Prior
Inventions

 

The
following is a complete list of all inventions or improvements relevant to the subject matter of my employment by the Company that have
been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company:

 

	 	☐	No
    inventions or improvements	 
	 	 	 	 
	 	☐	See
    below:	 
	 	 		 
	 	 	 	 
	 	 		 
	 	 	 	 
	 	 		 
	 	 	 	 
	 	☐	Additional
    sheets attached	 
	 	 	 	 
	 	The following is a list of all patents and patent applications in which I have been named as an inventor:
	 	 	 	 
	 	☐	None	 
	 	 	 	 
	 	☐	See
    below:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]